GTC Biotherapeutics (fka GTCB)

[DewDiligence]

Re: Pros and cons of an FDA advisory panel

>...there is potential for people to talk about goat genes invading humans etc.<

That’s why I would rather not have an advisory panel, where the mike will be open to people who want to express all kinds of wild and crazy viewpoints about transgenics.

>I still think an advisory panel is more positive than negative because of the strong data. I would think the opposite if data were weak because the usual setup for the FDA has been to murder biotechs with weak data using advisory panels.<

I disagree strongly. In general, weak data imply that you want a panel because it’s the best chance to pull a rabbit out of the hat, while strong data imply that you do not want a panel because it’s better to let sleeping dogs lie. Regards, Dew